Urinary angiotensinogen-melatonin ratio in gestational diabetes and preeclampsia (2022)
Source: Frontiers in Molecular Biosciences. Unidade: ICB
Subjects: FISIOLOGIA, SISTEMA RENINA-ANGIOTENSINA, ECLÂMPSIA, MELATONINA, DOENÇAS CARDIOVASCULARES, DIABETES MELLITUS, GRAVIDEZ NO DIABETES, BIOMARCADORES
ABNT
VALIAS, Gabriela Ribeiro et al. Urinary angiotensinogen-melatonin ratio in gestational diabetes and preeclampsia. Frontiers in Molecular Biosciences, v. 9, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.3389/fmolb.2022.800638. Acesso em: 19 nov. 2024.APA
Valias, G. R., Gomes, P. R. L., Amaral, F. G. do, Alnuaimi, S., Monteiro, D., O'Sullivan, S., et al. (2022). Urinary angiotensinogen-melatonin ratio in gestational diabetes and preeclampsia. Frontiers in Molecular Biosciences, 9, 1-9. doi:10.3389/fmolb.2022.800638NLM
Valias GR, Gomes PRL, Amaral FG do, Alnuaimi S, Monteiro D, O'Sullivan S, Zangaro R, Cipolla Neto J, Acuna J, Baltatu OC, Campos LA. Urinary angiotensinogen-melatonin ratio in gestational diabetes and preeclampsia [Internet]. Frontiers in Molecular Biosciences. 2022 ; 9 1-9.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fmolb.2022.800638Vancouver
Valias GR, Gomes PRL, Amaral FG do, Alnuaimi S, Monteiro D, O'Sullivan S, Zangaro R, Cipolla Neto J, Acuna J, Baltatu OC, Campos LA. Urinary angiotensinogen-melatonin ratio in gestational diabetes and preeclampsia [Internet]. Frontiers in Molecular Biosciences. 2022 ; 9 1-9.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fmolb.2022.800638